Disclosure 0001780649-26-000014-5

SEC FORM 4

$6,816,994.56

Adaptive Biotechnologies Corp (ADPT)

Sale of 278,472 shares at $24.48 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Adaptive Biotechnologies Corp (ADPT)." Disclosed 2026-08-19. https://desqlong.com/cards/0001780649-26-000014-5 (retrieved 2026-09-26).